Aytac Bektas Nisa, Yenigul Nefise Nazli, Pakay Kaan, Dincgez Burcu, Yuce Bilgin Elif, Ustundag Yasemin, Ustunyurt Emin
University of Health Sciences School of Medicine Bursa Yuksek Ihtisas Research and Training Hospital, Department of Obstetrics and Gynecology, Bursa, Turkey.
University of Health Sciences School of Medicine Bursa Yuksek Ihtisas Research and Training Hospital, Department of Obstetrics and Gynecology, Division of Perinatology, Bursa, Turkey.
J Perinatol. 2024 Jul;44(7):1029-1034. doi: 10.1038/s41372-024-01925-3. Epub 2024 Mar 18.
In this study, we aimed to evaluate BPA levels in the maternal serum and amniotic fluid of patients diagnosed with NTD. In addition, we wanted to investigate the relationship between neurodevelopmental defects, such as neural tube defects (NTD), and BPA levels.
This prospective observational study was carried out at Bursa Yüksek İhtisas Training and Research Hospital between April 15, 2021, and April 15, 2022. The study consisted of 92 patients between the ages of 18-45 who had an amniocentesis at 15-22 weeks of gestation. The patients were divided into two groups according to the indications of amniocentesis. Group 1 contained the patients with abnormal maternal serum screening results or cell-free DNA results and abnormal ultrasonography findings (45 patients). Group 2 contained the patients with a pre-diagnosis of NTD (47 patients). The first 5 cc fluids and maternal serum samples taken during the amniocentesis procedure of all patients were delivered to the biochemistry laboratory. The BPA values between groups were compared.
A statistically significant difference was found between the two groups in terms of amniotic fluid BPA levels (36.66 (19.00:82.00) and 39.62 (19.02-73.87)) and maternal blood BPA levels (22.26 (12.60-228) and 47.81 (12.89-228.39)). In cases with NTD, amniotic fluid BPA levels and maternal blood BPA levels were significantly higher than the control group. When AUC values were compared, the AFP numerical value was higher than the amniotic fluid and maternal blood BPA levels.
Plastic, which is indispensable for modern life, may negatively affect fetal development in intrauterine life. The data in this study says that high maternal blood BPA may be associated with NTD.
在本研究中,我们旨在评估被诊断为神经管缺陷(NTD)患者的母血清和羊水中双酚A(BPA)的水平。此外,我们想研究神经管缺陷等神经发育缺陷与双酚A水平之间的关系。
这项前瞻性观察研究于2021年4月15日至2022年4月15日在布尔萨尤克谢希萨特培训和研究医院进行。该研究包括92名年龄在18 - 45岁之间、在妊娠15 - 22周时进行羊膜穿刺术的患者。根据羊膜穿刺术的指征将患者分为两组。第1组包含母血清筛查结果或游离DNA结果异常以及超声检查结果异常的患者(45例)。第2组包含预先诊断为神经管缺陷的患者(47例)。在所有患者的羊膜穿刺术过程中采集的前5毫升液体和母血清样本被送至生物化学实验室。比较两组之间的双酚A值。
两组在羊水双酚A水平(36.66(19.00:82.00)和39.62(19.02 - 73.87))和母血双酚A水平(22.26(12.60 - 228)和47.81(12.89 - 228.39))方面存在统计学上的显著差异。在患有神经管缺陷的病例中,羊水双酚A水平和母血双酚A水平显著高于对照组。当比较曲线下面积(AUC)值时甲胎蛋白(AFP)数值高于羊水和母血双酚A水平。
现代生活不可或缺的塑料制品可能会对子宫内胎儿发育产生负面影响。本研究中的数据表明,母血中高双酚A水平可能与神经管缺陷有关。